AtriCure prices $24M stock offering | Wall Street Beat

January 16, 2013 by MassDevice staff

AtriCure says it plans to offer nearly 3.5 million shares at $7.25 apiece, hoping to drum up some $24 million for its atrial fibrillation device. Wall Street Beat

AtriCure (NSDQ:ATRC) priced a public offering of nearly 3.5 million shares of stock at $7.25 per share, saying it expects net proceeds of about $23.5 million.

The West Chester, Ohio-based medical device company said it granted underwriter Piper Jaffray a 30-day over-allotment option for another 521,000 shares.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.